Hyperthyroid levels of TSH correlate with low bone mineral density: The HUNT 2 study

European Journal of Endocrinology

Volumn 161, Issue 5, 2009, Pages 779-786

  Svare, Anders ^a,b   Nilsen, Tom Ivar Lund ^c   Bjøro, Trine ^d,e   Forsmo, Siri ^a   Schei, Berit ^a   Langhammer, Arnulf ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b Namsos Hospital   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; LIOTHYRONINE; THYROXINE;

ADULT; AGED; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; FOREARM; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; OSTEOPENIA; OSTEOPOROSIS; POPULATION RESEARCH; PRIORITY JOURNAL; SELF REPORT; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; BLOOD; CROSS-SECTIONAL STUDY; MIDDLE AGED; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; STATISTICAL MODEL;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; FOREARM; HUMANS; HYPERTHYROIDISM; LOGISTIC MODELS; MIDDLE AGED; OSTEOPOROSIS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 70449722919     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0139     Document Type: Article

References (39)

1. Galliford TM, Murphy E, Williams AJ, Bassett JHD & Williams GR. Effects of thyroid status on bone metabolism: a primary role for thyroid stimulating hormone or thyroid hormone? Minerva Endocrinologica 2005 30 237-246.
2. Cooper DS. Hyperthyroidism. Lancet 2003 362 459-468.
3. Greenspan SL & Greenspan FS. The effect of thyroid hormone on skeletal integrity. Annals of Internal Medicine 1999 130 750-758.
4. Fraser SA, Anderson JB, Smith DA & Wilson GM. Osteoporosis and fractures following thyrotoxicosis. Lancet 1971 1 981-983.
5. Linde J & Friis T. Osteoporosis in hyperthyroidism estimated by photon absorptiometry. Acta Endocrinologica 1979 91 437-448. (Pubitemid 9239685)
6. Toh SH, Claunch BC & Brown PH. Effect of hyperthyroidism and its treatment on bone mineral content. Archives of Internal Medicine 1985 145 883-886.
7. Ben-Shlomo A, Hagag P, Evans S &Weiss M. Early postmenopausal bone loss in hyperthyroidism. Maturitas 2001 39 19-27.
8. Udaykumar N, Chandrasekaran M, Rasheed MH, Suresh RV & Sivaprakash S. Evaluation of bone mineral density in thyrotoxicosis. Singapore Medical Journal 2006 47 947-950. (Pubitemid 44745428)
9. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D & Vogt TM. Risk factors for hip fracture in white women. New England Journal of Medicine 1995 332 767-773.
10. Wejda B, Hintze G, Katschinski B, Olbricht T & Benker G. Hip fractures and the thyroid: a case-control study. Journal of Internal Medicine 1995 237 241-247.
11. Seeley DG, Kelsey J, Jergas M & Nevitt MC. Predictors of ankle and foot fractures in older women. Journal of Bone and Mineral Research 1996 11 1347-1355. (Pubitemid 26282536)
12. Bauer DC, Ettinger B, Nevitt MC & Stone KL. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Annals of Internal Medicine 2001 134 561-568. (Pubitemid 32245317)
13. Ahmed LA, Schirmer H, Berntsen GK, Fonnebo V & Joakimsen RM. Self-reported diseases and the risk of non-vertebral fractures: the Tromsø study. Osteoporosis International 2006 17 46-53. (Pubitemid 41798027)
14. Kim DJ, Khang YH, Koh J-M, Shong YK & Kim GS. Low normal TSH levels are associated with low bone mineral density in healthy postmenopausal women. Clinical Endocrinology 2006 64 86-90.
15. Morris MS. The association between serum thyroid-stimulating hormone in its reference range and bone status in postmenopausal American women. Bone 2007 40 1128-1134.
16. Vestergaard P, Weeke J, Hoeck HC, Nielsen HK, Rungby J, Rejnmark L, Laurberg P & Mosekilde L. Fractures in patients with primary idiopathic hypothyroidism. Thyroid 2000 10 335-340. (Pubitemid 30256863)
17. Vestergaard P, Rejnmark L & Mosekilde L. Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcified Tissue International 2005 77 139-144. (Pubitemid 41569743)
18. Holmen J, Midthjell K, Krüger Ø, Langhammer A, Holmen TL, Bratberg GH, Vatten L & Lund-Larsen PG. The Nord-Trøndelag Health study 1995-1997 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiologi 2003 13 19-32.
19. Bjøro T, Holmen J, Krüger Ø, Midthjell K, Hunstad K, Schreiner T, Sandnes L & Brochmann H. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trøndelag (HUNT). European Journal of Endocrinology 2000 143 639-647.
20. Berntsen GKR, Tollan A, Magnus JH, Søgaard AJ, Ringberg T & Fønnebø V. The Tromsø Study: artifacts in forearm bone densitometry - prevalence and effect. Osteoporosis International 1999 10 425-432.
21. Greendale GA, Lee NP & Arriola ER. The menopause. Lancet 1999 353 571-580.
22. Surks MI, Goswami G & Daniels SH. Controversy in clinical endocrinology. The thyrotropin reference range should remain unchanged. Journal of Clinical Endocrinology and Metabolism 2005 90 5489-5496.
23. Orimo H, Sugioka Y, Fukunaga M, Muto Y, Hotokebuchi T, Gorai I, Nakamura T, Kushida K, Tanaka H, Ikai T & Oh-Hashi Y. Diagnostic criteria for primary osteoporosis. The Committee of the Japanese Society for bone and mineral research for development of diagnostic criteria of osteoporosis. Journal of Bone and Mineral Metabolism 1998 16 139-150.
24. Kanis JA & Gluer CC. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporosis International 2000 11 192-202.
25. von Recklinghausen FC. Die Fibrose oder deformierende Ostitis, die Osteomalazie und die osteoplastische Karzinose in ihren gegeseitigen Beziehungen. In Festschrift Rudolph Virchow, pp 1-89. Berlin: Reiner G, 1891.
26. Abe E, Marians RC, Yu W, Wu X-B, Ando T, Li Y, Iqbal J, Eldeiry L, Rajendren G, Blair HC, Davies TF & Zaidi M. TSH is a negative regulator of skeletal remodelling. Cell 2003 115 151-162. (Pubitemid 37329579)
27. Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Biondi B, Iorio S, Giustina A, Amato G & Carella C. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. Journal of Bone and Mineral Research 2005 20 480-486. (Pubitemid 40293497)
28. Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O'Brian S, Schiavi SC, McPherson JM & Vukicivic S. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats. Journal of Bone and Mineral Research 2007 22 849-859. (Pubitemid 351339745)
29. Sun J, Vukicevic S, Beliram R, Yang G, Sendak R, McPherson J, Zhu L-L, Iqbal J, Latif R, Natrajan A, Arabi A, Yamoah K, Moonga BS, Gabet Y, Davies TF, Bab I, Abe E, Sampath K & Zaidi M. Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss. PNAS 2008 105 42889-44294. (Pubitemid 351754373)
30. Hase H, Ando T, Eldeiry L, Brebene A, Peng Y, Liu L, Amano H, Davies TF, Sun L, Zaidi M & Abe E. TNFα mediates the skeletal effects of thyroid-stimulating hormone. PNAS 2006 103 12849-12854. (Pubitemid 44298650)
31. Heemstra KA, van der Deure WM, Peeters RP, Hamdy NA, Stokkel MP, Corssmit EP, Romijn JA, Visser TJ & Smit JW. Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma. European Journal of Endocrinology 2008 159 69-76.
32. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS & Weissman NJ. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. Journal of the American Medical Association 2004 291 228-238. (Pubitemid 38082818)
33. Lee WY, Oh KW, Rhee EJ, Jung CH, Kim SW, Yun EJ, Tae HJ, Baek KH, Kang MI, Choi MG, Yoo HJ & Park SW. Relationship between subclinical thyroid dysfunction and femoral neck bone mineral density in women. Archives of Medical Research 2006 37 511-516.
34. Grimnes G, Emaus N, Joakimsen R, Figenschau Y & Jorde R. The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Tromsø study. Thyroid 2008 18 1147-1155.
35. Rosen CJ & Adler RA. Longitudinal changes in lumbar bone mineral density among thyrotoxic patients after attainment of euthyroidism. Journal of Clinical Endocrinology and Metabolism 1992 75 1531-1534.
36. Grant DJ, McMurdo MET, Mole PA & Paterson CR. Is previous hyperthyroidism still a risk factor for osteoporosis in postmenopausal women? Clinical Endocrinology 1995 43 339-345.
37. Langdahl BL, Loft AG, Eriksen EF, Mosekilde L & Charles P. Bone mass, bone turnover, calcium homeostasis, and body composition in surgically radioiodine-treated former hyperthyroid patients. Thyroid 1996 6 169-175. (Pubitemid 26279407)
38. Langdahl BL, Loft AG, Eriksen EF, Mosekilde L & Charles P. Bone mass, bone turnover, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy. Thyroid 1996 6 161-168. (Pubitemid 26279406)
39. Marshall D, Johnell J & Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fracture. BMJ 1996 312 1254-1259. (Pubitemid 26147662)